FINHUB Insights

COR · Q3 FY24 · Apr 1 – Jun 30, 2024

Cencora Q3 FY24: where the revenue came from and where it went

Cencora Q3 FY24: revenue $74.2B (+11% year over year). Net profit $0.5B. Largest cohort US Healthcare Solutions $67.2B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2024
Reported
Jul 31, 2024 10-Q
Sankey diagram of Cencora's income statement for Q3 FY24: revenue of $74.2 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$74.2B +11% year over year
Gross profit$2.4B 3% margin
Operating profit$0.7B 1% margin
Net profit$0.5B 1% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Jun 30, 2024).
ItemValueShare of revenueYear over year
Revenue 74.2 100% +11%
US Healthcare Solutions 67.2 91% +12%
International Healthcare 7.1 10% +0%
Cost of revenue−71.897%
Gross profit2.43% margin+0pp
SG&A−1.42%+0pp
Other−0.40%+0pp
Operating profit0.71% margin+0pp
Tax−0.2
Net profit0.51%+0pp
Filing on EDGAR More quarters of COR

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters